The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
On-Demand Educational Webinars
This session explains the benefits of implementing the UDI such as immediate device status updates through collaboration with manufacturers and…
Webcast
Howard Mann, vice president, supply chain management at Cardiovascular Care Group discusses the basics of value analysis and value based purchasing
On-Demand Educational Webinars
This webinar takes a deep look at industries that have evolved successful and meaningful supplier relationships to advance shared value among a…
On-Demand Educational Webinars
Outsourcing of hospital functions is a common and growing practice in the U.S. and comprises on average 25% of total non-labor spend in hospitals.…
Webcast
In this three-part series, Lisa Tonkinson and Chris Wiekert discuss how the Revenue Cycle can impact your supply chain when embarking on a new soft
Webcast
Continuing from Part 1, this short session updates supply chain professionals on the design and timing of the new small bore tubing connectors maki